Pathways of plasma cell differentiation in autoimmunity
Pathways of plasma cell differentiation in autoimmunity
批准号:
8420431
负责人:
Loren D Erickson
金额:
$35.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-08 至 2017-01-31
关键词:
Adoptive TransferAffectAntibodiesAntibody FormationAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-LymphocytesBindingBone MarrowCell CountCell SurvivalCellsCellular biologyCongenic MiceDataDevelopmentFamilyGenerationsGoalsHomeostasisImmuneImmune responseKnockout MiceLifeLongevityLymphoidLymphoid TissueMaintenanceMature BoneMediatingModelingMolecularMusNew ZealandOrganPathway interactionsPhysiologicalPlasma CellsProductionPropertyProteinsRecombinantsRegulationReportingRoleSignal TransductionSourceStagingT-LymphocyteTALL-1 proteinTestingThinkingTimeTissuesTransgenic MiceTumor Necrosis Factor Receptorautoreactive B cellbis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)aminecell typedesigneffective therapymembermouse modelplasma cell differentiationprogenitorreceptorresearch studyself-renewal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Pathways of plasma cell differentiation in autoimmunity. The overall goal of this project is to directly assess the role of BCMA in the regulation of plasma cell (PC) survival and the development of autoantibodies. BCMA is a member of the TNF receptor family and was first described by our group as a critical receptor on PCs that, upon binding its ligands BAFF and APRIL, mediates their long-term survival in the bone marrow (BM). This has led to our hypothesis that BCMA has an intrinsic effect on PC longevity by directly delivering pro-survival signals to mature BM PCs that serve as a long-term source for antibody production. However, signaling through BCMA could also affect earlier B cell intermediates that give rise to BM PCs and, thus, contribute indirectly to the development and persistence of antibody- producing PCs in the BM. We have previously demonstrated that the development of a reservoir of BM PCs could be achieved in a T cell-dependent immune response through the generation of a unique BM resident cell type, the PC progenitor (PCpre), with the capacity for both long-term self renewal and terminal differentiation to long-lived PCs in
the BM1-3. New data provided in this application demonstrates that the ability of PCpre to give rise to long-lived BM PCs is dependent on BAFF/APRIL. We further hypothesize that the capacity to sustain long-lived PCs is achieved in part at the PCpre stage, specifically through BCMA signaling in PCpre, which controls both their maintenance in the BM and their differentiation to long-lived PCs. Thus, BCMA signaling is required for the establishment and stability of a normal repertoire of specific, protective antibodies. In the absence of this mechanism, we predicted that the normal functions of PC-derived stable antibody production in immune homeostasis would be disrupted. In support of this hypothesis, we recently reported that, in both the lpr and New Zealand-derived autoimmune-prone mouse models, BCMA deficiency causes dramatic B cell lymphoproliferation, accumulation of PCpre and long-lived PCs in secondary lymphoid organs, enhanced autoantibody production, increased numbers of BAFF-producing cells, and early lethality compared to BCMA- sufficient autoimmune-prone mice4. These observations suggest that, in autoimmune-prone mice, signals through BCMA on B cells help control B cell homeostasis and the stringent elimination of autoreactive B cells. In this proposal, we will use a combination of transgenic, congenic, and knockout mice to characterize BCMA signaling at sequential stages of the PC differentiation pathway. This strategy will allow us to determine the physiologic role of BCMA in PC biology as well as intrinsic alterations in B cells, exogenous signals from innate immune cells, and T cell help in controlling abnormal development and survival of long-lived PCs in autoimmune-prone mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
-
批准号:10649670
-
项目类别:
-
资助金额:$80.24万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
Tracking Extracellular Vesicles Derived From B Cells in Autoimmunity
-
批准号:10450549
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
Tracking Extracellular Vesicles Derived From B Cells in Autoimmunity
-
批准号:10549373
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
-
批准号:10818690
-
项目类别:
-
资助金额:$11.22万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
-
批准号:10851057
-
项目类别:
-
资助金额:$28.66万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
-
批准号:10842540
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
-
批准号:10536408
-
项目类别:
-
资助金额:$81.78万
-
财政年份:2022
-
负责人:Loren D Erickson
-
依托单位:
Skin-associated B cells in allergy
-
批准号:10088409
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2020
-
负责人:Loren D Erickson
-
依托单位:
High-dimensional profiling of B cells in food allergy
-
批准号:9121279
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2016
-
负责人:Loren D Erickson
-
依托单位:
Pathways of plasma cell differentiation in autoimmunity
-
批准号:8699294
-
项目类别:
-
资助金额:$3.86万
-
财政年份:2012
-
负责人:Loren D Erickson
-
依托单位:
Pathways of plasma cell differentiation in autoimmunity
-
批准号:8605829
-
项目类别:
-
资助金额:$47.11万
-
财政年份:2012
-
负责人:Loren D Erickson
-
依托单位:
Pathways of plasma cell differentiation in autoimmunity
-
批准号:8290811
-
项目类别:
-
资助金额:$38.26万
-
财政年份:2012
-
负责人:Loren D Erickson
-
依托单位:
Pathways of B cell differentiation into plasma cells
-
批准号:8310464
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2011
-
负责人:Loren D Erickson
-
依托单位:
COBRE: DMS: CHEMOKINE RESPONSIVENESS OF PLASMA CELLS IN AUTOIMMUNITY
-
批准号:7381260
-
项目类别:
-
资助金额:$3.59万
-
财政年份:2006
-
负责人:Loren D Erickson
-
依托单位:
Role of TLRs in plasma cell differentiation and survival
-
批准号:6964650
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2005
-
负责人:Loren D Erickson
-
依托单位:
COBRE: DMS: CHEMOKINE RESPONSIVENESS OF PLASMA CELLS IN AUTOIMMUNITY
-
批准号:7170490
-
项目类别:
-
资助金额:$21.73万
-
财政年份:2005
-
负责人:Loren D Erickson
-
依托单位:
Role of TLRs in plasma cell differentiation and survival
-
批准号:7271176
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2005
-
负责人:Loren D Erickson
-
依托单位:
Role of TLRs in plasma cell differentiation and survival
-
批准号:7121141
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2005
-
负责人:Loren D Erickson
-
依托单位:
COBRE: DMS: CHEMOKINE RESPONSIVENESS OF PLASMA CELLS IN AUTOIMMUNITY
-
批准号:6981473
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2004
-
负责人:Loren D Erickson
-
依托单位:
ROLE OF TNF FAMILY MEMBERS IN MEMORY B CELL DEVELOPMENT
-
批准号:6070134
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:Loren D Erickson
-
依托单位:
海外基金